Sukhjit Starch & Chemicals Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 28 May 2026 | Agricultural Food & other Products | Market Cap: ₹513 Cr

The company achieved 8.41% revenue growth in FY '25, reaching INR 1,486 crore. The company demonstrated resilience with 8.41% revenue growth in FY '25 despite challenges.

From Sukhjit Starch & Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

159

Market Cap

₹513 Cr

P/E Ratio

15.0

How does Sukhjit Starch & Chemicals Ltd rank in Agricultural Food & other Products?

Compare Sukhjit Starch & Chemicals Ltd against every Agricultural Food & other Products company this quarter on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

Sukhjit Starch & Chemicals Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹402 Cr, net profit ₹15 Cr.

Full financials →

📊 Revenue & Sales Performance

  • The company achieved 8.41% revenue growth in FY '25, reaching INR 1,486 crore.
  • Volume growth existed even with depressed starch prices, driven by a diverse product portfolio.
  • Capacity expansion from 1,600 TPD to 2,000 TPD by next year, with expected utilization around 75–80%.
  • Positive impact of derivatives expansion expected to be visible from Q1 FY '26, starch expansion effects from Q3.
  • Strategy focuses on diversifying product mix and growing profitably rather than just increasing starch production.
  • Future growth will depend on stabilizing maize and starch prices and improved export opportunities.
  • The company intends to deepen customer engagement, pursue strategic initiatives, and leverage manufacturing expansions prudently.
  • While short-term demand growth may be muted due to oversupply and tariffs, medium to long-term prospects are positive, contingent on favorable demand-supply balance and geopolitical trade developments.

📈 Profitability & Margins

  • The company demonstrated resilience with 8.41% revenue growth in FY '25 despite challenges.
  • Margins were pressured due to high maize prices and starch price declines, but stabilization is expected in H2 FY '26 as maize availability improves.
  • Ongoing manufacturing expansion (from 1,600 TPD to 2,000 TPD) is on track, expected to contribute positively from Q3 FY '26.
  • Focus on diverse product mix and derivatives is aimed at more profitable growth and reducing reliance on starch alone.
  • Management cautious on industry overcapacity and pricing volatility; strategic expansions will be paced based on market conditions.
  • Expect improving starch prices and lower maize costs to drive margin recovery and profitability in coming quarters.
  • No specific EPS guidance shared, but with growth strategy and operational efficiencies, future earnings are anticipated to improve steadily.

🏗️ Capital Expenditure Plans

  • The company’s manufacturing expansion project remains on track and is expected to enhance production capacity, enabling better service to customers across various sectors.
  • Expansion includes a 400 ton per day (TPD) plant expected to contribute meaningful volumes starting Q3 FY '26, with some positive impacts on derivatives visible from the June quarter.
  • Despite industry overcapacity and tariff headwinds affecting exports, the company remains committed to growing its business prudently and will monitor the external environment before deciding on the scale and timing of further expansion.
  • The company aims to optimize product mix and capacities to grow more profitably and maintain a diverse portfolio.
  • Future capital allocation decisions will be guided by how market conditions, including maize prices and export opportunities, evolve.

💰 Fundraising & Capital Structure

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The company has significantly reduced its long-term bank borrowings to nearly nil.
  • The debt-equity ratio is low at 0.15, indicating a strong financial position.
  • Management emphasizes conserving capital and taking a "wait and watch" approach amid current market volatility.
  • Future expansion and growth initiatives will depend on how external market conditions evolve, but no specific fundraising plans are disclosed.
  • No indication of equity issuance or new debt raising was provided during the call.

📋 Order Book & Pipeline

The transcript provided does not mention any details regarding the current or expected order book or pending orders for The Sukhjit Starch & Chemicals Limited. The discussion primarily focuses on operational performance, capacity expansion, raw material pricing, starch and derivatives pricing, market conditions, and strategic outlook. There is no specific information related to order backlog or pending orders in the provided pages.

Key Metrics

Frequently Asked Questions

What were Sukhjit Starch & Chemicals Ltd Q4 FY25 results?

The company achieved 8.41% revenue growth in FY '25, reaching INR 1,486 crore. The company demonstrated resilience with 8.41% revenue growth in FY '25 despite challenges.

What is Sukhjit Starch & Chemicals Ltd share price analysis?

Sukhjit Starch & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 15.0 with a market cap of ₹513 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sukhjit Starch & Chemicals Ltd planning capital expenditure?

The company’s manufacturing expansion project remains on track and is expected to enhance production capacity, enabling better service to customers across various sectors.

Keep Sukhjit Starch & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Sukhjit Starch & Chemicals Ltd's management said in earlier quarters

Others in Agricultural Food & other Products this season

  • AWL Agri Busine. (Q4 FY25)

    Capex planned at INR 500-600 crores annually for maintenance and debottlenecking to support growth. Key concall takeaways from AWL Agri Business Ltd's Q4 FY25…

  • CCL Products (Q4 FY25)

    Volume growth for the full year was around 10%. Key concall takeaways from CCL Products (India) Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Marico (Q4 FY25)

    Marico has continued to invest aggressively in A&P (Advertising & Promotion), with an 18% increase in FY25 and 35% growth in Q4, focusing on strengthening core…

  • Zuari Industries Ltd (Q4 FY25)

    Overall standalone revenue grew 22% in FY25, with Sugar contributing the bulk while real estate contributions fluctuated. Key concall takeaways from Zuari…